Effect of Obesity on Immune Response to Pneumovax 23 (ROVE)
The Effect of Obesity on Immune Responses to Pneumococcal Polysaccharide Vaccine, ROVE Study
Sponsor: University of Florida
A observational or N/A phase clinical study on Obesity, this trial is completed. The trial is conducted by University of Florida and has accumulated 11 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2019 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2019 — Jun 2019 [monthly]
Active Not Recruiting
▶ Show 6 earlier versions
-
Oct 2018 — Apr 2019 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jul 2018 — Oct 2018 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Florida
For direct contact, visit the study record on ClinicalTrials.gov .